Rv. Haning et al., DEHYDROEPIANDROSTERONE-SULFATE AND ANOVULATION INCREASE SERUM INHIBINAND AFFECT FOLLICULAR FUNCTION DURING ADMINISTRATION OF GONADOTROPINS, The Journal of clinical endocrinology and metabolism, 78(1), 1994, pp. 145-149
To test the hypothesis that testosterone (T) derived from circulating
dehydroepiandrosterone sulfate (DS) or produced in excess within the a
novulatory ovary is a follicular regulator capable of stimulating inhi
bin secretion, DS and inhibin were determined by RIA in residual serum
samples from in vitro fertilization cycles and analyzed along with ot
her parameters using analysis of variance and stepwise multiple linear
regression after log transformation of the RIA data. It was predicted
that the serum concentration of inhibin would be higher in women with
anovulation than in normal subjects and that the serum inhibin concen
tration would have a positive regression coefficient on the serum DS c
oncentration. The serum concentrations of inhibin (P < 0.01) and estra
diol (P < 0.001) on the day of hCG treatment were higher in women with
anovulation than in normal subjects, as was the number of oocytes ret
rieved (P < 0.001). The FSH and LH doses (both P < 0.005) and age (P <
0.001) were significantly lower, and the average duration of gonadotr
opin therapy was 1 day shorter (P < 0.001) in anovulatory patients. Th
ere was no significant difference in serum DS (P > 0.2).Regression ana
lysis showed that serum inhibin was positively related to the number o
f oocytes (P < 0.001) and serum DS (P = 0.05), with an increase in ano
vulatory subjects (P < 0.025). The duration of treatment with gonadotr
opins was related positively to the patient's age (P < 0.001) and nega
tively to serum DS (P < 0.025), with a decrease in anovulatory subject
s (P < 0.025). The number of oocytes obtained was negatively related t
o age (P < 0.001) and positively to serum DS (P < 0.005). These data a
re consistent with a stimulatory effect of follicular T derived from e
ither circulating DS or the anovulatory ovary, which affects the secre
tion of inhibin, the duration of gonadotropin treatment, and the numbe
r of oocytes retrieved.